Cambridge Investment Research Advisors
TRAW icon

Cambridge Investment Research Advisors’s Traws Pharma TRAW Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29
Closed -$11K – 3178
2021
Q1 		$11K Hold
29
– – ﹤0.01% 2854
2020
Q4 		$5K Buy
+29
New +$3.37K ﹤0.01% 2704

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Cambridge Investment Research Advisors's TRAW Position: Q2 2021 in Review

Cambridge Investment Research Advisors sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 29 shares — an estimated $11K sold.

Cambridge Investment Research Advisors first reported a position in TRAW in Q4 2020 and held it in 2 quarters. The position peaked at $11K in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

  • Cambridge Investment Research Advisors reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 29 Traws Pharma shares in Q2 2021, an estimated $11K.
  • Cambridge Investment Research Advisors first reported a position in Traws Pharma in Q4 2020 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Traws Pharma position peaked at $11K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.